Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease

Clinical scores commonly used in the assessment of disease activity are unreliable at differentiating endoscopic remission from active CD, and despite this, a score based on a combination of fecal calprotectin and the HBI is a new promising tool for identifying endoscopies remission.